1. Home
  2. NTWK vs ELOX Comparison

NTWK vs ELOX Comparison

Compare NTWK & ELOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NetSol Technologies Inc.

NTWK

NetSol Technologies Inc.

N/A

Current Price

$6.07

Market Cap

71.1M

Sector

Technology

ML Signal

N/A

Logo Eloxx Pharmaceuticals Inc. Common Stock

ELOX

Eloxx Pharmaceuticals Inc. Common Stock

N/A

Current Price

$14.88

Market Cap

60.3M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
NTWK
ELOX
Founded
1997
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
71.1M
60.3M
IPO Year
1997
2013

Fundamental Metrics

Financial Performance
Metric
NTWK
ELOX
Price
$6.07
$14.88
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $38.25
AVG Volume (30 Days)
★ 118.4K
18.6K
Earning Date
09-28-2026
08-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 41.67
EPS
★ 0.25
N/A
Revenue
★ $78,145,875.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$24.16
★ N/A
Revenue Growth
★ 6.92
N/A
52 Week Low
$2.73
$10.00
52 Week High
$6.38
$23.40

Technical Indicators

Market Signals
Indicator
NTWK
ELOX
Relative Strength Index (RSI) 75.71 41.15
Support Level $3.05 $13.98
Resistance Level N/A $14.65
Average True Range (ATR) 0.35 1.26
MACD 0.11 -0.13
Stochastic Oscillator 81.77 11.83

Price Performance

Historical Comparison
NTWK
ELOX

About NTWK NetSol Technologies Inc.

NETSOL Technologies Inc is an information technology and enterprise software solutions provider to original equipment manufacturers (OEMs), dealerships, and financial institutions to sell, finance, and lease assets. The firm's products include Transcend Retail, Transcend Finance, Transcend Marketplace, Transcend Consultancy, and Transcend AI Labs, catering to its customers in the different stages of how assets are sold, financed, and leased. Its primary sources of revenue are licensing, subscriptions, modification, enhancement, and support of its suite of financial applications offered to businesses in the finance and leasing space, as well as automotive digital retail. The company has three reportable segments: Asia-Pacific, its key revenue-generating market, North America, and Europe.

About ELOX Eloxx Pharmaceuticals Inc. Common Stock

Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.

Share on Social Networks: